Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab
出版年份 2013 全文链接
标题
Histopathologic evaluation of liver metastases from colorectal cancer in patients treated with FOLFOXIRI plus bevacizumab
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 108, Issue 12, Pages 2549-2556
出版商
Springer Nature
发表日期
2013-05-24
DOI
10.1038/bjc.2013.245
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pathologic Response to Preoperative Chemotherapy in Colorectal Liver Metastases: Fibrosis, not Necrosis, Predicts Outcome
- (2012) George A. Poultsides et al. ANNALS OF SURGICAL ONCOLOGY
- Pathologic response to bevacizumab-containing chemotherapy in patients with colorectal liver metastases and its correlation with survival
- (2012) T. Gruenberger et al. SURGICAL ONCOLOGY-OXFORD
- Bevacizumab Improves Pathological Response of Colorectal Cancer Liver Metastases Treated with XELOX/FOLFOX
- (2010) Markus Klinger et al. ANNALS OF SURGICAL ONCOLOGY
- Extended Preoperative Chemotherapy Does Not Improve Pathologic Response and Increases Postoperative Liver Insufficiency After Hepatic Resection for Colorectal Liver Metastases
- (2010) Yoji Kishi et al. ANNALS OF SURGICAL ONCOLOGY
- Impact of bevacizumab on functional recovery and histology of the liver after resection of colorectal metastases
- (2010) D. A. Wicherts et al. BRITISH JOURNAL OF SURGERY
- Tumor necrosis is a new promising prognostic factor in colorectal cancer
- (2010) Marion J. Pollheimer et al. HUMAN PATHOLOGY
- Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials
- (2010) Fotios Loupakis et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial
- (2010) Gianluca Masi et al. LANCET ONCOLOGY
- Long-Term Outcome of Initially Unresectable Metastatic Colorectal Cancer Patients Treated with 5-Fluorouracil/Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Followed by Radical Surgery of Metastases
- (2009) Gianluca Masi et al. ANNALS OF SURGERY
- A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
- (2009) E Vasile et al. BRITISH JOURNAL OF CANCER
- Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases
- (2009) Yun Shin Chun JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Pathologic Response to Preoperative Chemotherapy: A New Outcome End Point After Resection of Hepatic Colorectal Metastases
- (2008) Dan G. Blazer et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal Cancer
- (2008) Brigit Gruenberger et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study
- (2008) Leonard B. Saltz et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More